Neurogene NGNE
NASDAQ NGNE
$27.15 -0.67 (-2.41%)
As of: Oct 1, 2026 · 10:07 AM EDT

Neurogene (NGNE) Other financing activities (2014 - 2024)

Updated

Neurogene's Other financing activities was $4.29 million in FY2024.

Analysis

Neurogene (NGNE) Other financing activities (2014 - 2024) Analysis & Trends

From FY2013 onward, Neurogene has reported Other financing activities for 4 years.

  • The FY2024 figure marks the highest annual Other financing activities since FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Neurogene 627.40 Mn 627.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 4.29 Mn
Dec 31, 2023 -1.96 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 100,000.00
Dec 31, 2014 -288.00
Sep 30, 2014 50,000.00
Jun 30, 2014 390,345.00
Mar 31, 2014 4.81 Mn
API Access

Neurogene Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NGNE&period=max&api_key=YOUR_API_KEY